NCT03334552View on ClinicalTrials.gov

Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 15, 2017

Primary Completion Date

May 31, 2024

Study Completion Date

August 31, 2024

Conditions
HIV/AIDS
Trial Locations (1)

Unknown

NIMR-Mbeya Medical Research Center (MMRC), Mbeya

All Listed Sponsors
collaborator

National Institute for Medical Research - Mbeya Medical Research Centre (NIMR-MMRC)

UNKNOWN

collaborator

University Clinic of Cologne, Department of Internal Medicine, Center for Molecular Medicine Cologne (CMMC)

UNKNOWN

collaborator

Max von Pettenkofer-Institute of the University of Munich (LMU), Department of Virology

UNKNOWN

lead

Michael Hoelscher

OTHER